SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-23-127396
Filing Date
2023-12-20
Accepted
2023-12-19 17:38:43
Documents
1
Group Members
HENRY A. PLAIN, JR.JEAN M. GEORGELIGHTSTONE VENTURES (A), L.P.LIGHTSTONE VENTURES II (A), L.P.LIGHTSTONE VENTURES II, L.P.LIGHTSTONE VENTURES, L.P.LSV ASSOCIATES II, LLCMICHAEL A. CARUSI

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2332991d1_sc13da.htm SC 13D/A 188111
  Complete submission text file 0001104659-23-127396.txt   189990
Mailing Address 2884 SAND HILL ROAD, SUITE 121 MENLO PARK CA 94025
Business Address 2884 SAND HILL ROAD, SUITE 121 MENLO PARK CA 94025 (617) 850-9700
LSV Associates, LLC (Filed by) CIK: 0001643828 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Subject) CIK: 0001810182 (see all company filings)

IRS No.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91585 | Film No.: 231498683
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)